nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—endothelium—colon cancer	0.0318	0.122	CbGeAlD
Ingenol Mebutate—PRKCA—blood vessel—colon cancer	0.0293	0.112	CbGeAlD
Ingenol Mebutate—PRKCD—renal system—colon cancer	0.024	0.0919	CbGeAlD
Ingenol Mebutate—PRKCD—lymphoid tissue—colon cancer	0.0199	0.0763	CbGeAlD
Ingenol Mebutate—PRKCD—bone marrow—colon cancer	0.0181	0.0695	CbGeAlD
Ingenol Mebutate—PRKCA—embryo—colon cancer	0.0175	0.0669	CbGeAlD
Ingenol Mebutate—PRKCD—vagina—colon cancer	0.0174	0.0665	CbGeAlD
Ingenol Mebutate—PRKCD—liver—colon cancer	0.0147	0.0561	CbGeAlD
Ingenol Mebutate—PRKCA—epithelium—colon cancer	0.0143	0.0546	CbGeAlD
Ingenol Mebutate—PRKCA—smooth muscle tissue—colon cancer	0.0137	0.0526	CbGeAlD
Ingenol Mebutate—PRKCA—renal system—colon cancer	0.0132	0.0506	CbGeAlD
Ingenol Mebutate—PRKCD—lymph node—colon cancer	0.0112	0.043	CbGeAlD
Ingenol Mebutate—PRKCA—lymphoid tissue—colon cancer	0.011	0.042	CbGeAlD
Ingenol Mebutate—PRKCA—digestive system—colon cancer	0.0109	0.0415	CbGeAlD
Ingenol Mebutate—Application site burn—Fluorouracil—colon cancer	0.00812	0.169	CcSEcCtD
Ingenol Mebutate—PRKCA—liver—colon cancer	0.00809	0.0309	CbGeAlD
Ingenol Mebutate—PRKCA—lymph node—colon cancer	0.0062	0.0237	CbGeAlD
Ingenol Mebutate—Scab—Fluorouracil—colon cancer	0.00535	0.112	CcSEcCtD
Ingenol Mebutate—Application site pain—Fluorouracil—colon cancer	0.00387	0.0808	CcSEcCtD
Ingenol Mebutate—Scab—Capecitabine—colon cancer	0.00374	0.0781	CcSEcCtD
Ingenol Mebutate—Ulcer—Irinotecan—colon cancer	0.00188	0.0392	CcSEcCtD
Ingenol Mebutate—Ulcer—Fluorouracil—colon cancer	0.0018	0.0376	CcSEcCtD
Ingenol Mebutate—Swelling—Fluorouracil—colon cancer	0.0014	0.0292	CcSEcCtD
Ingenol Mebutate—Ulcer—Capecitabine—colon cancer	0.00126	0.0262	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Fluorouracil—colon cancer	0.0011	0.0231	CcSEcCtD
Ingenol Mebutate—Swelling—Capecitabine—colon cancer	0.000979	0.0204	CcSEcCtD
Ingenol Mebutate—Eye pain—Capecitabine—colon cancer	0.000956	0.02	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Fluorouracil—colon cancer	0.000952	0.0199	CcSEcCtD
Ingenol Mebutate—Infestation—Fluorouracil—colon cancer	0.000952	0.0199	CcSEcCtD
Ingenol Mebutate—Ulcer—Methotrexate—colon cancer	0.000936	0.0195	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Fluorouracil—colon cancer	0.000926	0.0193	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Capecitabine—colon cancer	0.000772	0.0161	CcSEcCtD
Ingenol Mebutate—Erythema—Fluorouracil—colon cancer	0.000744	0.0155	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Capecitabine—colon cancer	0.000665	0.0139	CcSEcCtD
Ingenol Mebutate—Infestation—Capecitabine—colon cancer	0.000665	0.0139	CcSEcCtD
Ingenol Mebutate—Infection—Vincristine—colon cancer	0.000647	0.0135	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Capecitabine—colon cancer	0.000647	0.0135	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Vincristine—colon cancer	0.000639	0.0133	CcSEcCtD
Ingenol Mebutate—Infection—Irinotecan—colon cancer	0.00063	0.0131	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Irinotecan—colon cancer	0.000622	0.013	CcSEcCtD
Ingenol Mebutate—Infection—Fluorouracil—colon cancer	0.000603	0.0126	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Fluorouracil—colon cancer	0.000596	0.0124	CcSEcCtD
Ingenol Mebutate—Eye disorder—Capecitabine—colon cancer	0.000558	0.0116	CcSEcCtD
Ingenol Mebutate—Erythema—Capecitabine—colon cancer	0.00052	0.0109	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Methotrexate—colon cancer	0.000495	0.0103	CcSEcCtD
Ingenol Mebutate—Infestation—Methotrexate—colon cancer	0.000495	0.0103	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Methotrexate—colon cancer	0.000482	0.01	CcSEcCtD
Ingenol Mebutate—Infection—Capecitabine—colon cancer	0.000422	0.0088	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Capecitabine—colon cancer	0.000416	0.00868	CcSEcCtD
Ingenol Mebutate—Eye disorder—Methotrexate—colon cancer	0.000416	0.00867	CcSEcCtD
Ingenol Mebutate—Headache—Vincristine—colon cancer	0.000408	0.00851	CcSEcCtD
Ingenol Mebutate—Headache—Irinotecan—colon cancer	0.000397	0.00829	CcSEcCtD
Ingenol Mebutate—Erythema—Methotrexate—colon cancer	0.000387	0.00808	CcSEcCtD
Ingenol Mebutate—Headache—Fluorouracil—colon cancer	0.00038	0.00794	CcSEcCtD
Ingenol Mebutate—Infection—Methotrexate—colon cancer	0.000314	0.00655	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Methotrexate—colon cancer	0.00031	0.00646	CcSEcCtD
Ingenol Mebutate—PRKCA—Signaling by FGFR—PIK3CA—colon cancer	0.00028	0.000406	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—VEGFA—colon cancer	0.00028	0.000406	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—HNF4A—colon cancer	0.00028	0.000405	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—KRAS—colon cancer	0.000279	0.000404	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—PIK3CA—colon cancer	0.000279	0.000404	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—KRAS—colon cancer	0.000278	0.000403	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—PIK3CA—colon cancer	0.000278	0.000402	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—HRAS—colon cancer	0.000277	0.000402	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—CASP3—colon cancer	0.000269	0.000389	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Metabolism of RNA—AKT1—colon cancer	0.000268	0.000388	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000268	0.000387	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—EGFR—colon cancer	0.000267	0.000386	CbGpPWpGaD
Ingenol Mebutate—Headache—Capecitabine—colon cancer	0.000266	0.00555	CcSEcCtD
Ingenol Mebutate—PRKCD—Hemostasis—EP300—colon cancer	0.000265	0.000384	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—HRAS—colon cancer	0.000262	0.000379	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—PIK3CA—colon cancer	0.000261	0.000378	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—PIK3CA—colon cancer	0.000261	0.000378	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—HRAS—colon cancer	0.000261	0.000378	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—HRAS—colon cancer	0.00026	0.000376	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—HRAS—colon cancer	0.00026	0.000376	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—PIK3CA—colon cancer	0.000259	0.000375	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—HRAS—colon cancer	0.000258	0.000374	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—SRC—colon cancer	0.000258	0.000374	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—colon cancer	0.000258	0.000373	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—TGFB1—colon cancer	0.000257	0.000372	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CTNNB1—colon cancer	0.000257	0.000372	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—HRAS—colon cancer	0.000257	0.000372	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—PIK3CA—colon cancer	0.000257	0.000372	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—AKT1—colon cancer	0.000256	0.000371	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—PIK3CA—colon cancer	0.000256	0.00037	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—AKT1—colon cancer	0.000253	0.000367	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—CDKN1A—colon cancer	0.000253	0.000366	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—KRAS—colon cancer	0.000252	0.000365	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—VEGFA—colon cancer	0.000251	0.000364	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CDKN1A—colon cancer	0.000251	0.000364	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—BCL2L1—colon cancer	0.000251	0.000364	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—NRAS—colon cancer	0.000248	0.000359	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—BCL2L1—colon cancer	0.000248	0.000359	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000246	0.000356	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—AKT1—colon cancer	0.000245	0.000355	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—colon cancer	0.000243	0.000352	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—HRAS—colon cancer	0.000242	0.00035	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—HRAS—colon cancer	0.000242	0.00035	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—FGFR3—colon cancer	0.00024	0.000348	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—HRAS—colon cancer	0.00024	0.000347	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—EP300—colon cancer	0.000239	0.000346	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—CTNNB1—colon cancer	0.000238	0.000345	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000238	0.000344	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—HRAS—colon cancer	0.000237	0.000344	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—FGFR3—colon cancer	0.000237	0.000343	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—HRAS—colon cancer	0.000236	0.000342	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—SRC—colon cancer	0.000234	0.000339	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—SRC—colon cancer	0.000232	0.000336	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—PIK3CA—colon cancer	0.000231	0.000335	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—AKT1—colon cancer	0.000231	0.000335	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TGFB1—colon cancer	0.000231	0.000334	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—AKT1—colon cancer	0.00023	0.000333	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—AKT1—colon cancer	0.000229	0.000332	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—AKT1—colon cancer	0.000229	0.000332	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—AKT1—colon cancer	0.000228	0.00033	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—AKT1—colon cancer	0.000227	0.000328	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—NRAS—colon cancer	0.000225	0.000326	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—colon cancer	0.000224	0.000324	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—NRAS—colon cancer	0.000224	0.000324	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—TGFB1—colon cancer	0.000223	0.000323	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—FGFR3—colon cancer	0.000222	0.000321	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—EP300—colon cancer	0.000222	0.000321	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Transmission across Chemical Synapses—HRAS—colon cancer	0.000219	0.000317	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	0.000219	0.000317	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—HRAS—colon cancer	0.000214	0.00031	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—KRAS—colon cancer	0.000214	0.000309	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—AKT1—colon cancer	0.000213	0.000309	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—AKT1—colon cancer	0.000213	0.000309	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—AKT1—colon cancer	0.000212	0.000306	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—PPARG—colon cancer	0.000212	0.000306	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—AKT1—colon cancer	0.00021	0.000304	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—AKT1—colon cancer	0.000209	0.000302	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—colon cancer	0.000207	0.0003	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—EGFR—colon cancer	0.000205	0.000297	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—EGFR—colon cancer	0.000204	0.000295	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—APC—colon cancer	0.000204	0.000295	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CDH1—colon cancer	0.000203	0.000294	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000201	0.000291	CbGpPWpGaD
Ingenol Mebutate—Headache—Methotrexate—colon cancer	0.000198	0.00413	CcSEcCtD
Ingenol Mebutate—PRKCD—Hemostasis—PIK3CA—colon cancer	0.000196	0.000284	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—KRAS—colon cancer	0.000194	0.000281	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—MYC—colon cancer	0.000193	0.00028	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—KRAS—colon cancer	0.000192	0.000279	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—BRAF—colon cancer	0.000191	0.000277	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—colon cancer	0.00019	0.000275	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—AKT1—colon cancer	0.000189	0.000274	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—HRAS—colon cancer	0.000182	0.000263	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of mRNA—AKT1—colon cancer	0.00018	0.000261	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—AKT1—colon cancer	0.000179	0.000259	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—PIK3CA—colon cancer	0.000178	0.000258	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—PIK3CA—colon cancer	0.000177	0.000256	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CCND1—colon cancer	0.000175	0.000253	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDKN1A—colon cancer	0.000169	0.000245	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD8A—colon cancer	0.000169	0.000244	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—HRAS—colon cancer	0.000168	0.000243	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—HRAS—colon cancer	0.000165	0.000238	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—HRAS—colon cancer	0.000164	0.000237	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—EP300—colon cancer	0.000161	0.000233	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—AKT1—colon cancer	0.00016	0.000232	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CCND1—colon cancer	0.000156	0.000226	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FGFR3—colon cancer	0.000155	0.000225	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTGS2—colon cancer	0.000155	0.000224	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of RNA—AKT1—colon cancer	0.000154	0.000223	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—EP300—colon cancer	0.000152	0.000221	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN1A—colon cancer	0.000151	0.000219	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CTNNB1—colon cancer	0.00015	0.000217	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—SRC—colon cancer	0.000148	0.000215	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CTNNB1—colon cancer	0.000148	0.000214	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CDKN1A—colon cancer	0.000146	0.000212	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—AKT1—colon cancer	0.000145	0.000211	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—AKT1—colon cancer	0.000144	0.000209	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—VEGFA—colon cancer	0.000144	0.000209	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CDKN1A—colon cancer	0.000144	0.000209	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—BCL2L1—colon cancer	0.000144	0.000209	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—EP300—colon cancer	0.000144	0.000208	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—NRAS—colon cancer	0.000143	0.000206	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—APC—colon cancer	0.000143	0.000206	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—NRAS—colon cancer	0.000143	0.000206	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—MYC—colon cancer	0.00014	0.000203	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EP300—colon cancer	0.000139	0.000202	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CTNNB1—colon cancer	0.000138	0.0002	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FGFR3—colon cancer	0.000138	0.0002	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EP300—colon cancer	0.000137	0.000199	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ABCB1—colon cancer	0.000136	0.000197	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—SRC—colon cancer	0.000135	0.000196	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CDKN1A—colon cancer	0.000135	0.000196	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—BRAF—colon cancer	0.000134	0.000194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—AKT1—colon cancer	0.000134	0.000194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—SRC—colon cancer	0.000133	0.000193	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—TYMS—colon cancer	0.000133	0.000193	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TGFB1—colon cancer	0.000133	0.000192	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—NRAS—colon cancer	0.00013	0.000189	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—EGFR—colon cancer	0.00013	0.000188	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EP300—colon cancer	0.000129	0.000186	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—NRAS—colon cancer	0.000128	0.000186	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FGFR3—colon cancer	0.000127	0.000184	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MYC—colon cancer	0.000125	0.000182	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SRC—colon cancer	0.000125	0.000181	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—PIK3CA—colon cancer	0.000124	0.00018	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—KRAS—colon cancer	0.000123	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—KRAS—colon cancer	0.000123	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PPARG—colon cancer	0.000122	0.000176	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—MYC—colon cancer	0.000121	0.000175	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NRAS—colon cancer	0.00012	0.000174	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EGFR—colon cancer	0.000119	0.000172	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EGFR—colon cancer	0.000117	0.000169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—APC—colon cancer	0.000117	0.000169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CDH1—colon cancer	0.000117	0.000169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—PIK3CA—colon cancer	0.000113	0.000163	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—PIK3CA—colon cancer	0.000113	0.000163	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—KRAS—colon cancer	0.000112	0.000162	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MYC—colon cancer	0.000112	0.000162	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TGFB1—colon cancer	0.000112	0.000162	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—KRAS—colon cancer	0.000111	0.00016	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—BRAF—colon cancer	0.00011	0.000159	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EGFR—colon cancer	0.00011	0.000159	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—colon cancer	0.000109	0.000158	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—HRAS—colon cancer	0.000104	0.000151	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—HRAS—colon cancer	0.000104	0.000151	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—KRAS—colon cancer	0.000103	0.00015	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PIK3CA—colon cancer	0.000103	0.000149	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—colon cancer	0.000103	0.000149	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—PIK3CA—colon cancer	0.000102	0.000147	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—AKT1—colon cancer	0.000101	0.000147	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CASP3—colon cancer	0.0001	0.000145	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCND1—colon cancer	9.78e-05	0.000142	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CTNNB1—colon cancer	9.68e-05	0.00014	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HRAS—colon cancer	9.53e-05	0.000138	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PIK3CA—colon cancer	9.51e-05	0.000138	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CDKN1A—colon cancer	9.46e-05	0.000137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PPARG—colon cancer	9.45e-05	0.000137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—HRAS—colon cancer	9.39e-05	0.000136	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—AKT1—colon cancer	9.21e-05	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—AKT1—colon cancer	9.21e-05	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EP300—colon cancer	9e-05	0.00013	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGFR3—colon cancer	8.92e-05	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTGS2—colon cancer	8.87e-05	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HRAS—colon cancer	8.79e-05	0.000127	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SRC—colon cancer	8.75e-05	0.000127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CTNNB1—colon cancer	8.6e-05	0.000125	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VEGFA—colon cancer	8.52e-05	0.000123	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NRAS—colon cancer	8.42e-05	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—AKT1—colon cancer	8.41e-05	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CDKN1A—colon cancer	8.4e-05	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—AKT1—colon cancer	8.36e-05	0.000121	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—AKT1—colon cancer	8.29e-05	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APC—colon cancer	8.19e-05	0.000118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—NRAS—colon cancer	8.19e-05	0.000118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EP300—colon cancer	7.99e-05	0.000116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CTNNB1—colon cancer	7.94e-05	0.000115	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MYC—colon cancer	7.84e-05	0.000114	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TGFB1—colon cancer	7.82e-05	0.000113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—SRC—colon cancer	7.77e-05	0.000113	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—AKT1—colon cancer	7.77e-05	0.000112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CDKN1A—colon cancer	7.76e-05	0.000112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—BRAF—colon cancer	7.69e-05	0.000111	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EGFR—colon cancer	7.67e-05	0.000111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NRAS—colon cancer	7.48e-05	0.000108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—EGFR—colon cancer	7.46e-05	0.000108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTGS2—colon cancer	7.43e-05	0.000108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EP300—colon cancer	7.38e-05	0.000107	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KRAS—colon cancer	7.25e-05	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SRC—colon cancer	7.18e-05	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PIK3CA—colon cancer	7.13e-05	0.000103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—KRAS—colon cancer	7.04e-05	0.000102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MYC—colon cancer	6.93e-05	0.0001	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NRAS—colon cancer	6.9e-05	0.0001	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EGFR—colon cancer	6.81e-05	9.86e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PIK3CA—colon cancer	6.66e-05	9.64e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PIK3CA—colon cancer	6.47e-05	9.37e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—colon cancer	6.44e-05	9.32e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—KRAS—colon cancer	6.44e-05	9.32e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MYC—colon cancer	6.43e-05	9.31e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TGFB1—colon cancer	6.42e-05	9.29e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EGFR—colon cancer	6.29e-05	9.11e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—EP300—colon cancer	6.18e-05	8.95e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HRAS—colon cancer	6.16e-05	8.92e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—HRAS—colon cancer	5.99e-05	8.67e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—KRAS—colon cancer	5.94e-05	8.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PIK3CA—colon cancer	5.91e-05	8.56e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—AKT1—colon cancer	5.82e-05	8.43e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CASP3—colon cancer	5.77e-05	8.35e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCND1—colon cancer	5.62e-05	8.13e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CTNNB1—colon cancer	5.56e-05	8.05e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HRAS—colon cancer	5.47e-05	7.92e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PIK3CA—colon cancer	5.46e-05	7.9e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AKT1—colon cancer	5.44e-05	7.87e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CDKN1A—colon cancer	5.43e-05	7.86e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AKT1—colon cancer	5.29e-05	7.65e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EP300—colon cancer	5.17e-05	7.48e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HRAS—colon cancer	5.05e-05	7.31e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SRC—colon cancer	5.03e-05	7.28e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VEGFA—colon cancer	4.9e-05	7.09e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NRAS—colon cancer	4.84e-05	7e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—AKT1—colon cancer	4.83e-05	6.99e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—AKT1—colon cancer	4.8e-05	6.95e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PIK3CA—colon cancer	4.57e-05	6.62e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MYC—colon cancer	4.5e-05	6.52e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TGFB1—colon cancer	4.49e-05	6.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—AKT1—colon cancer	4.46e-05	6.46e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EGFR—colon cancer	4.41e-05	6.38e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KRAS—colon cancer	4.16e-05	6.02e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PIK3CA—colon cancer	3.82e-05	5.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AKT1—colon cancer	3.74e-05	5.41e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—colon cancer	3.7e-05	5.35e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HRAS—colon cancer	3.54e-05	5.12e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AKT1—colon cancer	3.12e-05	4.52e-05	CbGpPWpGaD
